ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » General Practice

Top General Practice Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EFREN VALENCIA MD

General Practice

5,913

$281K

182
62 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

48%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $53

DONALD SCHWARTZ M.D.

General Practice

5,596

$281K

649
266 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

42%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $53

HOOVER PERRY MD

General Practice

5,150

$280K

437
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 25%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $53

GRANT STEVENSON M.D.

General Practice

4,495

$226K

206
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $53

CHARLES NICHOLS MD

General Practice

4,211

$192K

249
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $53

ASHOK ALUR MD

General Practice

4,116

$200K

308
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 25%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $53

SAM PERSAD MD

General Practice

4,072

$181K

224
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 25%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $53

KENNETH DESIMONE MD

General Practice

3,407

$174K

200
145 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

34%
patients receiving schedule three controlled substances

Avg: 25%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $53

JAMES OWEN MD

General Practice

2,976

$138K

227
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 25%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $53

ELZER FULLER M.D.

General Practice

2,794

$144K

309
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 25%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $53

JERRY BRACKETT M.D.

General Practice

2,349

$51K

186
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

91%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

5%
prescriptions for brand name drugs

Avg: 22%

$22
Average prescription price

Avg: $53

PAUL DUNCAN D.O.

General Practice

2,174

$130K

214
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $53

JOSE ALZADON M.D.

General Practice

1,926

$58.7K

92
0 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

93%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$30
Average prescription price

Avg: $53

CHARLES WALLER MD

General Practice

1,716

$76.4K

174
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 25%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $53

FRANCINE MOSLEY M.D., MAED

General Practice

1,514

$90K

250
111 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $53

STANLEY HSIEH M.D.

General Practice

1,184

$70.5K

123
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

37%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $53

DOINA SAXMAN M.D.

General Practice

1,055

$31.5K

102
12 are 65+

90%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 22%

$30
Average prescription price

Avg: $53

LARRY PARSONS MD

General Practice

916

$47.7K

188
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $53

JEFFREY LOVE M.D.

General Practice

698

$12.2K

414
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 22%

$17
Average prescription price

Avg: $53

MICHAEL GAVIN MD

General Practice

415

$10.6K

77
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 25%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 22%

$26
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank